AstraZeneca to Present Transformative Data at ESMO Asia 2017 Congress from Pivotal Trials Showing Potential New Standards of Care in Non-small Cell Lung Cancer
Phase III FLAURA data, including new data in patients with CNS metastases, confirm Tagrisso as potential new standard of care as 1st-line therapy in EGFR-mutated NSCLC New data in EGFR mutatio......